Susquehanna International Group
LSTA icon

Susquehanna International Group’s Lisata Therapeutics LSTA Stock Holding History

Susquehanna International Group’s Portfolio LSTA Stock Details LSTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-7,473
Closed -$137K – 13560
2021
Q3 		$137K Sell
7,473
-727
-9% -$14.3K ﹤0.01% 11859
2021
Q2 		$198K Buy
8,200
+1,913
+30% +$45.3K ﹤0.01% 11608
2021
Q1 		$182K Buy
6,287
+5,000
+389% +$152K ﹤0.01% 11503
2020
Q4 		$28K Sell
1,287
-2,146
-63% -$50.9K ﹤0.01% 10853
2020
Q3 		$93K Buy
+3,433
New +$109K ﹤0.01% 9951
2016
Q1 		– Sell
-199
Closed -$32K – 9389
2015
Q4 		$32K Sell
199
-266
-57% -$48.8K ﹤0.01% 9176
2015
Q3 		$104K Sell
465
-160
-26% -$40.1K ﹤0.01% 9116
2015
Q2 		$176K Buy
625
+98
+19% +$36.4K ﹤0.01% 9382
2015
Q1 		$201K Buy
527
+11
+2% +$5.96K ﹤0.01% 8630
2014
Q4 		$292K Sell
516
-21
-4% -$14.3K ﹤0.01% 8180
2014
Q3 		$446K Sell
537
-70
-12% -$61.3K ﹤0.01% 7415
2014
Q2 		$593K Buy
607
+188
+45% +$183K ﹤0.01% 7145
2014
Q1 		$443K Buy
419
+128
+44% +$139K ﹤0.01% 6938
2013
Q4 		$298K Buy
+291
New +$288K ﹤0.01% 7584

Other funds holding LSTA

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
RC
Rangeley Capital New Canaan, Connecticut $103M AUM 77.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
PenderFund Capital Management Vancouver, British Columbia, Canada $639M AUM 31.05% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Susquehanna International Group's LSTA Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Lisata Therapeutics (LSTA) in Q1 2026: 11,604 shares worth $58.1K. The stake represents ﹤0.01% of the portfolio and ranks #12596 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in LSTA as recently as Q3 2024.

Susquehanna International Group first reported a position in LSTA in Q4 2013 and has held it in 23 quarters since. The position peaked at $502K in Q2 2015. 34 funds tracked by Wall St. Rank hold LSTA as of Q1 2026.

  • Susquehanna International Group held 11,604 shares of Lisata Therapeutics worth $58.1K as of Q1 2026.
  • Lisata Therapeutics was a new Susquehanna International Group position in Q1 2026.
  • Lisata Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #12596 holding.
  • Susquehanna International Group first reported a position in Lisata Therapeutics in Q4 2013 and has held it in 23 quarters since.
  • Susquehanna International Group's Lisata Therapeutics position peaked at $502K in Q2 2015.
  • 34 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.